• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Characteristics of prognosis and response to an imidazole carboxamide in malignant melanoma.

作者信息

Nathanson L, Wolter J, Horton J, Colsky J, Shnider B I, Schilling A

出版信息

Clin Pharmacol Ther. 1971 Nov-Dec;12(6):955-62. doi: 10.1002/cpt1971126955.

DOI:10.1002/cpt1971126955
PMID:5134998
Abstract
摘要

相似文献

1
Characteristics of prognosis and response to an imidazole carboxamide in malignant melanoma.恶性黑色素瘤的预后特征及对咪唑甲酰胺的反应
Clin Pharmacol Ther. 1971 Nov-Dec;12(6):955-62. doi: 10.1002/cpt1971126955.
2
Clinical experience with 5-(3,3-bis(2-chloroethyl)-1-triazeno)imidazole-4-carboxamide (NSC-82196) in the treatment of metastatic malignant melanoma.5-（3,3-双（2-氯乙基）-1-三氮烯基）咪唑-4-甲酰胺（NSC-82196）治疗转移性恶性黑色素瘤的临床经验
Cancer Chemother Rep. 1972 Oct;56(5):671-7.
3
Chemotherapy of disseminated malignant melanoma with dimethyl triazeno imidazole carboxamide and dactinomycin.用二甲基三氮烯咪唑甲酰胺和放线菌素对播散性恶性黑色素瘤进行化疗。
Cancer. 1973 Oct;32(4):756-60. doi: 10.1002/1097-0142(197310)32:4<756::aid-cncr2820320404>3.0.co;2-6.
4
Study of 5-(3,3-dimethyl-1-triazeno)imidazole-4-carboxamide (NSC-45388) in patients with disseminated melanoma.5-（3,3-二甲基-1-三氮烯基）咪唑-4-甲酰胺（NSC-45388）治疗播散性黑色素瘤患者的研究。
Cancer Chemother Rep. 1973 Feb;57(1):83-4.
5
Intra-arterial infusion therapy with 5-(3,3-dimethyl-1-triazeno) imidazole-4-carboxamide (NSC 45388) for malignant melanoma.采用5-（3,3-二甲基-1-三氮烯基）咪唑-4-甲酰胺（NSC 45388）进行动脉内灌注治疗恶性黑色素瘤。
Cancer. 1973 Oct;32(4):749-55. doi: 10.1002/1097-0142(197310)32:4<749::aid-cncr2820320403>3.0.co;2-1.
6
Dacarbazine for malignant melanoma.达卡巴嗪用于治疗恶性黑色素瘤。
Med Lett Drugs Ther. 1974 Mar 15;16(6):27-8.
7
Chemotherapy of sarcomas with a combination of adriamycin and dimethyl triazeno imidazole carboxamide.阿霉素与二甲基三氮烯咪唑甲酰胺联合用于肉瘤的化疗。
Cancer. 1972 Dec;30(6):1632-8. doi: 10.1002/1097-0142(197212)30:6<1632::aid-cncr2820300632>3.0.co;2-s.
8
Central nervous system complications after combination treatment with adriamycin (NSC-123127) and 5-(3,3-dimethyl-1-triazeno)imidazole-4-carboxamide (NSC-45388).阿霉素（NSC - 123127）与5 -（3,3 - 二甲基 - 1 - 三氮烯基）咪唑 - 4 - 甲酰胺（NSC - 45388）联合治疗后的中枢神经系统并发症
Cancer Chemother Rep. 1974 Sep-Oct;58(5 Pt 1):753-4.
9
Evaluation of 1-(2-chloroethyl-3-4-methylcyclohexyl)-1-nitrosourea (methyl-CCNU, NSC 95441) versus combined imidazole carboxamide (NSC 45338) and vincristine (NSC 67574) in palliation of disseminated malignant melanoma.
Cancer. 1974 Mar;33(3):615-8. doi: 10.1002/1097-0142(197403)33:3<615::aid-cncr2820330304>3.0.co;2-f.
10
5-(3,3-dimethyl-l-triazeno)-imidazole-4-carboxamide (DTIC, DIC, NSC-45388)--a new antitumor agent with activity against malignant melanoma.
Eur J Cancer (1965). 1972 Feb;8(1):85-92. doi: 10.1016/0014-2964(72)90087-4.

引用本文的文献

1
More than Just Skin-Deep: A Review of Imaging's Role in Guiding CAR T-Cell Therapy for Advanced Melanoma.不止于表面：影像学在指导晚期黑色素瘤CAR-T细胞治疗中的作用综述
Diagnostics (Basel). 2023 Mar 5;13(5):992. doi: 10.3390/diagnostics13050992.
2
Translating Molecules into Imaging-The Development of New PET Tracers for Patients with Melanoma.将分子转化为成像——黑色素瘤患者新型正电子发射断层显像（PET）示踪剂的研发
Diagnostics (Basel). 2022 Apr 29;12(5):1116. doi: 10.3390/diagnostics12051116.
3
WITHDRAWN: Systemic treatments for metastatic cutaneous melanoma.
撤回：转移性皮肤黑色素瘤的全身治疗
Cochrane Database Syst Rev. 2018 Feb 7;2(2):CD001215. doi: 10.1002/14651858.CD001215.pub2.
4
State of melanoma: an historic overview of a field in transition.黑色素瘤的现状：一个处于转型期领域的历史概述
Hematol Oncol Clin North Am. 2014 Jun;28(3):415-35. doi: 10.1016/j.hoc.2014.02.010.
5
Experience with interferon alpha 2b combined with dacarbazine in the treatment of metastatic malignant melanoma.干扰素α2b联合达卡巴嗪治疗转移性恶性黑色素瘤的经验
Med Oncol. 1995 Mar;12(1):35-40. doi: 10.1007/BF01571406.
6
Pharmacokinetics of dacarbazine (DTIC) and its metabolite 5-aminoimidazole-4-carboxamide (AIC) following different dose schedules.达卡巴嗪（DTIC）及其代谢产物5-氨基咪唑-4-甲酰胺（AIC）在不同给药方案后的药代动力学。
Cancer Chemother Pharmacol. 1982;9(2):103-9. doi: 10.1007/BF00265388.
7
Chemotherapy of malignant melanoma with dimethyl traizeno imidazole carboxamide (DITC) and nitrosourea derivatives (BCNU, CCNU).用二甲基三嗪咪唑甲酰胺（DITC）和亚硝基脲衍生物（卡莫司汀、洛莫司汀）治疗恶性黑色素瘤。
Ann Surg. 1974 Aug;180(2):167-74. doi: 10.1097/00000658-197408000-00007.
8
Combination chemotherapy of dacarbazine and fotemustine in disseminated malignant melanoma. Experience of the French Study Group.达卡巴嗪与福莫司汀联合化疗用于播散性恶性黑色素瘤。法国研究小组的经验。
Cancer Chemother Pharmacol. 1990;27(2):81-4. doi: 10.1007/BF00689087.